GENE OASIS PTE. LTD.

Gene Oasis is a Singapore-registered business group that develops and manufactures natural bioactive ingredients, innovative products and efficient delivery systems built on a strong portfolio of proprietary technologies and intellectual property. Its GO BioEnterprise commercial arm extracts next-generation peptide compositions primarily from edible bird nests and operates two business pillars: a sustainable food raw materials supply platform based on proprietary extraction technologies, and the development and commercialisation of novel milk-based peptide formulations. Gene Oasis combines a dedicated scientific advisory board, state-of-the-art manufacturing and an in-house factory to drive discovery, development and commercialisation of bio-pharmaceutical and nutraceutical products. The company collaborates with prestigious research institutions to expand and commercialise its IP and focuses research efforts across induced pluripotent stem cells, telomere and mitochondria therapies, immuno- and ER therapies, mesenchymal stem cells, metabolomics, precision diagnostics, microRNAs, glyco-therapeutics, exosomes and neuromedicine to achieve cellular regeneration, health and vitality.